Armata Pharmaceuticals (ARMP) Cash & Equivalents Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -68.22% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 988.88% |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 214.58% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 15.64% |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 4.77% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 17.50% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -4.13% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 3.35% |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 67.78% |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | -59.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -59.33% |
| Dec 31, 2025 | -6.49% |
| Sep 30, 2025 | -13.66% |
| Jun 30, 2025 | -83.72% |
| Mar 31, 2025 | -69.13% |
| Dec 31, 2024 | -31.29% |
| Sep 30, 2024 | -28.45% |
| Jun 30, 2024 | 111.99% |
| Mar 31, 2024 | 50.80% |
| Dec 31, 2023 | -8.95% |
| Sep 30, 2023 | -5.61% |
| Jun 30, 2023 | -66.32% |
| Mar 31, 2023 | -45.90% |
| Dec 31, 2022 | 44.36% |
| Sep 30, 2022 | 110.19% |
| Jun 30, 2022 | 110.87% |
| Mar 31, 2022 | 106.67% |
| Dec 31, 2021 | 6.62% |
| Sep 30, 2021 | -23.98% |
| Jun 30, 2021 | -11.37% |
| Mar 31, 2021 | -7.25% |
| Dec 31, 2020 | 59.94% |
| Sep 30, 2020 | 82.80% |
| Jun 30, 2020 | 49.98% |
| Mar 31, 2020 | 292.88% |
| Dec 31, 2019 | -37.57% |
| Sep 30, 2019 | -35.12% |
| Jun 30, 2019 | -14.47% |
| Mar 31, 2019 | -24.91% |
| Dec 31, 2018 | 88.29% |
| Sep 30, 2018 | 73.37% |
| Jun 30, 2018 | 72.10% |
| Mar 31, 2018 | 272.66% |
| Dec 31, 2017 | 0.00% |
| Sep 30, 2017 | 94.73% |
| Jun 30, 2017 | 25.45% |
| Mar 31, 2017 | -64.33% |
| Dec 31, 2016 | -45.23% |
| Sep 30, 2016 | -66.20% |
| Jun 30, 2016 | -50.22% |